JUAN LAMA
Pilots at 1/2 Campus Ave, San Diego, CA

License number
California A4313169
Issued Date
Mar 2016
Expiration Date
Mar 2018
Category
Airmen
Type
Authorized Aircraft Instructor
Address
Address
4230 Campus Ave, San Diego, CA 92103

Personal information

See more information about JUAN LAMA at radaris.com
Name
Address
Phone
Juan Lama, age 57
3771 4Th Ave, San Diego, CA 92103
Juan Lama, age 57
4230 Campus Ave, San Diego, CA 92103
Juan Lama, age 57
8827 Via Andar, San Diego, CA 92122
(619) 452-7858

Professional information

Juan Lama Photo 1

Founder Ceo At Retrovirox Inc.

Position:
Member at San Diego Tech Coast Angels, President, Founder CEO at RetroVirox Inc.
Location:
Greater San Diego Area
Industry:
Biotechnology
Work:
San Diego Tech Coast Angels since Apr 2009 - Member RetroVirox Inc. since Nov 2007 - President, Founder CEO La Jolla Institute For Molecular Medicine Sep 2004 - Aug 2007 - Associate Professor University of California San Diego Jan 2000 - Aug 2004 - Associate Research Scientist La Jolla Institute for Allergy and Immunology 1998 - 2000 - Research Scientist Salk Institute for Biological Studies Sep 1995 - 1998 - Postdoctoral Scientist Institut Pasteur 1995 - 1995 - Visiting Scientist Centro de Biología Molecular 1990 - 1994 - Ph.D. Molecular Biology State University of New York at Stony Brook Jan 1992 - Dec 1992 - Visiting Scientist
Education:
Universidad Autónoma de Madrid 1990 - 1994
Ph.D., Molecular Virology
State University of New York at Stony Brook 1992 - 1992
Universidad Autónoma de Madrid 1985 - 1990
BS, Molecular Biology - Biochemistry
Skills:
Virology, Molecular Biology, Drug Discovery, Infectious Diseases, HCV, Biochemistry, Biotechnology, Cell Based Assays, Pharmaceuticals, Vaccines, Life Sciences, Microbiology, Genetics, Diagnostics, flow cytometry, Clinical, CRO, Immunology, Animal Models, Gene Therapy, Lifesciences, ELISA, Flow Cytometry, Pharmaceutical Industry, Assay Development, Cell Culture, Cell, Hardware Diagnostics, Biomarkers, High Throughput Screening, Protein Chemistry, Clinical Research, Proteomics
Interests:
Entrepreneurial activities Investment opportunities Partnership and collaboration opportunities Executive Management Virology Drug Discovery Biotechnology Gene Therapy Molecular Biology
Honor & Awards:
1988 Fellowship from Univ. Autónoma de Madrid 1989 Fellowship from Spanish Research Council 1990 Extraordinary Prize for the Master Thesis 1991 Fellowship from the Spanish Research Council 1991 Fellowship from “Fundación Caja Madrid” 1992 Grant Research Foundation of New York (SUNY, Stony Brook) 1994 Extraordinary Prize for Ph.D. Thesis on the Molecular Biology of Polioviruses 1995 EMBO Short-Term fellowship to work at the Institut Pasteur 1996 Fellowship Fundación Ramón Areces to work at the Salk Institute 1996 Fellowship Human Frontier Science Program (HFSP) 1999 Member, Center for AIDS Research, UCSD 2000 Member, UCSD Cancer Center 2001 Charter member, National Hispanic Science Network (USA) 2005 Member Minority Mentoring Program (American Association of Microbiology) 2006 Member, Editorial Board Retrovirology 2006-13 Ad hoc member NIAID NIH Study Sections committees: AIDS Discovery (ADDT); AIDS Molecular Biology; and several SBIR/STTR Study Sections


Francisco De La Lama Photo 2

Francisco De La Lama

Position:
Advisor at Grupo Ciag
Location:
Greater San Diego Area
Industry:
Consumer Services
Work:
Grupo Ciag since Jun 2008 - Advisor Telcom Services, Inc Jun 2006 - Jan 2010 - Chief Operating Officer Cintiva Financial Corporation Feb 2003 - Jun 2006 - VP Sales
Education:
Universidad del Noreste
University of San Diego High School
Skills:
Services Operations Management, Business Development, Team Leadership & Collaboration, Budgeting/Forecasting/P&L, Reorganizations, Brand Development, Strategic Joint Venture & Partnerships, International Business Development, Strategic Planning & Execution, Sales and CSR Management, Exceeding Financial Objectives Marketing Expertise


Juan Lama Photo 3

Methods For Treating Hiv By Inhibiting Cd4 Down-Modulation

US Patent:
2008014, Jun 19, 2008
Filed:
Mar 11, 2005
Appl. No.:
11/908378
Inventors:
Juan Lama - San Diego CA, US
Assignee:
The Regents of the University of California - Oakland CA
International Classification:
A61K 38/00, A61K 31/70, G01N 33/53, C12N 15/00
US Classification:
514 8, 514 44, 435 72, 435 79, 4353201
Abstract:
The present invention provides methods for inhibiting the ability of HIV genes products to bind to the cytoplasmic domain of a CD4 receptor. This domain is necessary to the ability of the HIV Nef and Vpu gene products to connect the CD4 receptor to cellular degradation pathways. The present invention provides a method for introducing a modified CD4 receptor into a cell, and inhibitors thereof, to treat HIV infection and CD4 receptor down-modulation. The present invention is also directed to a method for screening compounds for the ability to inhibit CD4 down-modulation.